Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age9-16
SponsorUniversity Children's Hospital, Zurich

About this trial

Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was feared. Recent data proof that the risk for malignancy was overestimated. Nowadays still a lot of patients express their wish for surgical removal out of aesthetic reasons and psychological impacts. Many patients and families experience stigmatization because of the nevus. To proof a medical indication for surgical removal the investigators want to evaluate the quality of life and stigmatization before and after nevus surgery.

Eligibility criteria

Qualifiers

patients with a congenital melanocytic nevi of at least 2 cm2 that will be removed surgically

age between 9 months and 16 years

Disqualifiers

mental retardation of the child

insufficient knowledge of the German language of both parents

severe comorbidities

previous therapies done for the CMN (dermabrasion, surgery, laser)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed